Listar por autor "Edwards, Christopher J."
Mostrando ítems 1-1 de 1
-
Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: a phase III, randomised, controlled trial (PALACE 3)
Edwards, Christopher J.; Blanco García, Francisco J; Crowley, Jeffrey; Birbara, Charles A.; Jaworski, Janusz; Aelion, Jacob; Stevens, Randall M.; Vessey, Adele; Zhan, Xiaojiang; Bird, Paul (BMJ, 2016-01-20)[Abstract] Objective. To evaluate apremilast treatment in patients with active psoriatic arthritis, including current skin involvement, despite prior therapy with conventional disease-modifying antirheumatic drugs and/or ...